Health Care·Life Sciences Tools & Services·$5.6B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.11 | N/A | -4.35% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.11 | N/A | -4.35% |
| Revenue | N/A | N/A | N/A |
Tone: Defensive
Management expressed concerns about market conditions affecting performance. They did not offer specific guidance for future earnings.
Management did not provide specific guidance for future quarters.
The company acknowledged challenges in the current market environment.
Bruker Corp's earnings report showed a miss on EPS, which contributed to a significant drop in stock price by 29.34%. The lack of revenue data and forward guidance indicates uncertainty about the company's future performance. Investors may be reacting to broader market challenges highlighted by management during the call.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
BANCO BRADESCO S A ADR
Oct 27, 2008